[1] 刘景瑜,曹欣,郭庚,等.FRAT1生物学特性的研究进展[J].国际遗传学杂志,2015,38(1):35-40,46. [2] ZHANG B, LI N, ZHANG H.Knockdown of homeobox B5(HOXB5) inhibits cell proliferation, migration, and invasion in non-small cell lung cancer cells through inactivation of the Wnt/β-catenin pathway[J].Oncol Res,2018,26(1):37-44. [3] 张勇, 曹红一, 王恩华. Frat1与TCF4在非小细胞肺癌(NSCLC)中表达的相关性及意义[J]. 现代肿瘤医学, 2012, 20(6):1175-1178. [4] PAN F, SHEN F Z, YANG L J, et al. Inhibitory effects of XAV939 on the proliferation of small-cell lung cancer H446 cells and Wnt/β-catenin signaling pathway in vitro[J]. Oncol Lett, 2018, 16(2):1953-1958. [5] 李高兵,蔡东平,毛张凡.川芎嗪通过调控Wnt信号通路抑制肺癌细胞增殖、侵袭和迁移的机制研究[J].现代肿瘤医学,2019,27(12):2035-2040. [6] DIMAKAKOS E, LIVANIOS K, GKIOZOS I,et al.New data for venous thromboembolism in patients with small cell lung cancer:A review[J].Phlebology, 2018,33(8):517-522. [7] 吕婷婷,吕欣,郭庚.FRAT1与肿瘤的相关性研究进展[J].医学综述,2014,20(20):3691-3693. [8] WERNER T V, HART M, NICKELS R, et al. MiR-34a-3p alters proliferation and apoptosis of meningioma cells in vitro and is directly targeting SMAD4, FRAT1 and BCL2[J]. Aging (Albany NY), 2017, 9(3):932-954. [9] ZHU K X, GUO J Q, WANG H J, et al. FRAT1 expression regulates proliferation in colon cancer cells[J]. Oncol Lett, 2016, 12(6):4761-4766. [10] YU Q G, SHANG L, YU H B, et al. Silencing of FRAT1 by siRNA inhibits the proliferation of SGC7901 human gastric adenocarcinoma cells[J]. Biomed Rep, 2016, 4(2):223-226. [11] FAN W H, DU F J, LIU X J, et al. Knockdown of FRAT1 inhibits hypoxia-induced epithelial-to-mesenchymal transition via suppression of the Wnt/β-catenin pathway in hepatocellular carcinoma cells[J]. Oncol Rep, 2016, 36(5):2999-3004. [12] 王苏雅, 于庆功, 谷伟, 等. 沉默FRAT1基因对结肠癌HT-29细胞增殖与凋亡的影响及其机制研究[J]. 中国实验诊断学, 2014, 18(2):195-199. [13] ZHANG W, XIONG H, ZOU Y M,et al.Frequently rearranged in advanced T cell lymphomas-1 demonstrates oncogenic properties in prostate cancer[J].Mol Med Rep,2016,14(4):3551-3558. [14] STOOTHOFF W H, CHO J H, MCDONALD R P,et al.FRAT-2 preferentially increases glycogen synthase kinase 3 beta-mediated phosphorylation of primed sites, which results in enhanced tau phosphorylation[J].J Biol Chem,2005,280(1):270-276. [15] 卢迎宏, 王丹, 井海云. 苦参碱对oxLDL诱导的血管平滑肌细胞炎症反应及增殖凋亡的影响及分子机制研究[J]. 中国免疫学杂志, 2018, 34(4):537-543. [16] JIA W, WU W, YANG D,et al.Histone demethylase JMJD3 regulates fibroblast-like synoviocyte-mediated proliferation and joint destruction in rheumatoid arthritis[J].FASEB J,2018,32(7):4031-4042. [17] WANG Y, CONG W, WU G,et al.MiR-376a suppresses the proliferation and invasion of non-small-cell lung cancer by targeting c-Myc[J].Cell Biol Int, 2018, 42(1):25-33. [18] ZOU J, LI X L, SHI Z M,et al.Effects of C-myc gene silencing on interleukin-1β-induced rat chondrocyte cell proliferation, apoptosis and cytokine expression[J].J Bone Miner Metab,2018,36(3):286-296. [19] WU J H, ZHANG Y H, SUN L, et al. Cyclin D1 expression by histiocytes may mimic cyclin D1-positive proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma[J]. Pathol Res Pract, 2018, 214(1):72-75. [20] CHEN J, LI X, CHENG Q,et al.Effects of cyclin D1 gene silencing on cellproliferation, cell cycle, and apoptosis of hepatocellular carcinoma cells[J].J Cell Biochem,2018,119(2):2368-2380. [21] WANG B, SUN L W, LI J D, et al. MiR-577 suppresses cell proliferation and epithelial-mesenchymal transition by regulating the WNT2B mediated Wnt/β-catenin pathway in non-small cell lung cancer[J]. Mol Med Rep, 2018, 18(3):2753-2761. [22] WANG D P, GU L L, XUE Q, et al. CtBP2 promotes proliferation and reduces drug sensitivity in non-small cell lung cancer via the Wnt/β-catenin pathway[J]. Neoplasma, 2018, 65(6):888-897. [23] CHEN Z Y, DU Y, WANG L,et al.iR-543 promotes cell proliferation and metastasis of renal cell carcinoma by targeting Dickkopf 1 through the Wnt/β-catenin signaling pathway[J].J Cancer,2018,9(20):3660-3668. [24] GUO W X, SHEN F Z, XIAO W J, et al. Wnt inhibitor XAV939 suppresses the viability of small cell lung cancer NCI-H446 cells and induces apoptosis[J]. Oncol Lett, 2017, 14(6):6585-6591. |